Skip to ContentSkip to Navigation
Rijksuniversiteit Groningenfounded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons prof. dr. A.A. (Adriaan) Voors

Publicaties

Effects of Finerenone on Readmissions for Heart Failure: Insights From the FINEARTS-HF Trial

Nanoparticle-Mediated Delivery of Adenosine 5′-Monophosphate Enhances 5-Oxoprolinase Activity to Mitigate Oxidative Stress in Heart Failure

Obesity and inactivity cluster the strongest risk factor for the development of heart failure in a population-based study

A comparison of the four most commonly used formulae to adjust the QT-interval for heart rate in 22,000 healthy subjects

Activation of Neutrophil Extracellular Trap Formation in Patients with Heart Failure and a Preserved Ejection Fraction

Acute Heart Failure: Transitioning From Symptom-Based Care to Remission

Alcohol consumption and incident heart failure in men and women

A multicentre, randomized, double-blind, active and placebo-controlled study of pecavaptan, a dual V1a/V2 vasopressin receptor antagonist, in patients with acute heart failure: The AVANTI trial

Anaemia in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trial

Assessing Benefit in Patients With Heart Failure and Reduced Ejection Fraction: Analysis of the VICTORIA Trial Using Novel Prognostic Risk Stratification

Pers/media

Men Have High Levels Of Enzyme Key To COVID-19

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

Novità nel trattamento dello scompenso cardiaco acuto

Health Industry News

PRNewswire Latest Health News

EMPULSE shows empagliflozin benefit in acute heart failure

Journal of Cardiac Failure Launches Rapid Publication Platform to Spark Discourse